Hyloris Pharmaceuticals SA HYL-BE:Euronext Brussels

*Data is delayed | EUR
Last | 9:07 AM CEST
14.38quote price arrow up+0.18 (+1.27%)
Volume
50
52 week range
12.65 - 19.10
Loading...
  • Open14.22
  • Day High14.38
  • Day Low14.22
  • Prev Close14.20
  • 52 Week High19.10
  • 52 Week High Date01/06/22
  • 52 Week Low12.65
  • 52 Week Low Date07/05/21

Key Stats

  • Market Cap379.45M
  • Shares Out25.83M
  • 10 Day Average Volume5,629.36
  • Dividend-
  • Dividend Yield-
  • Beta0.75
  • YTD % Change-16.88

KEY STATS

  • Open14.22
  • Day High14.38
  • Day Low14.22
  • Prev Close14.20
  • 52 Week High19.10
  • 52 Week High Date01/06/22
  • 52 Week Low12.65
  • 52 Week Low Date07/05/21
  • Market Cap379.45M
  • Shares Out25.83M
  • 10 Day Average Volume5,629.36
  • Dividend-
  • Dividend Yield-
  • Beta0.75
  • YTD % Change-16.88

RATIOS/PROFITABILITY

  • EPS (TTM)-0.45
  • P/E (TTM)-32.04
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Hyloris Pharmaceuticals SA

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Hyloris Pharmaceuticals is a Belgium-based specialty pharmaceutical company. Its focus is on re-engineering cardiovascular products. Additionally, it also further develops and improves already-approved pharmaceuticals and established products, creating new and different solutions. The Company’s diverse product-development portfolio spans a wide range of therapeutic indications and dosage forms.
Address
Boulevard Gustave Kleyer 17
Liege
4000
Belgium